About ImpediMed

ImpediMed is a global medical technology company that specializes in developing, manufacturing, and distributing non-invasive medical devices using Bioimpedance Spectroscopy (BIS) technology. Their flagship product, the SOZO® Digital Health Platform, provides rapid and detailed analysis of a patient’s fluid and tissue composition in less than 30 seconds. This platform is crucial for healthcare professionals, including surgeons, oncologists, and therapists, as it aids in the early detection and management of various conditions.

For physicians, the SOZO platform offers significant advantages in proactive patient care. Its primary application is the early detection of secondary lymphedema, a chronic swelling often resulting from cancer treatments. The L-Dex® analysis, a feature of SOZO, can detect subtle fluid shifts, enabling identification of subclinical lymphedema up to 10 months before visible symptoms appear, thereby allowing for timely intervention to prevent progression. The technology is also referenced in NCCN Clinical Practice Guidelines in Oncology for screening at-risk cancer patients for lymphedema, highlighting its clinical importance and integration into established care protocols. The cloud-connected platform facilitates remote monitoring and provides real-time, actionable insights, supporting coordinated and personalized care across various specialties.

Focus Areas

lymphedema detection and management fluid status monitoring body composition analysis sarcopenia risk assessment heart health management medical weight management cancer survivorship

Business Intelligence

TechnologyCloud-connected digital health platform utilizing Bioimpedance Spectroscopy (BIS) technology

What Physicians Need to Know

Lymphedema Detection & Management
ImpediMed specializes in the early detection and management of lymphedema, particularly breast cancer-related lymphedema (BCRL), using their SOZO® Digital Health Platform with L-Dex® analysis. Their technology can detect subclinical lymphedema (fluid changes as small as 36 ml) before visible symptoms appear, enabling early intervention with compression garments that can reduce progression to chronic lymphedema by 95%. The SOZO system is the only FDA-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema.
Fluid Status Monitoring
The SOZO Digital Health Platform provides accurate and non-invasive fluid status monitoring by measuring total body water, extracellular fluid (ECF), and intracellular fluid (ICF) volumes. This is crucial for managing chronic conditions like heart failure, where early detection of fluid overload can improve outcomes and reduce hospital readmissions. The HF-Dex™ analysis specifically helps clinicians understand dynamic changes in fluid volume for heart health management.
Body Composition Analysis
ImpediMed's BodyComp™ Analysis, powered by BIS technology, offers a comprehensive picture of body composition, including fat mass, lean mass, skeletal muscle mass, and fluid volumes, along with phase angle for cellular health. This goes beyond traditional BMI and weight measurements, providing insights into changes over time due to treatment or lifestyle. Segmental BodyComp™ Analysis further allows for detailed analysis of fluid, muscle, and lean soft tissue in individual limbs.
Sarcopenia Risk Assessment
The SOZO Digital Health Platform has received FDA clearance for sarcopenia risk assessment, making it the only FDA-cleared BIS solution for this purpose. It uses BodyComp™ muscle mass indices to identify patients at risk of sarcopenia, a condition characterized by muscle loss that can impact treatment outcomes, recovery, and quality of life, especially in oncology patients and those with chronic conditions like heart failure, type 2 diabetes, and obesity.
Heart Health Management
ImpediMed's SOZO platform, with its HF-Dex™ analysis, provides advanced body composition and fluid insights for heart health management. It can detect fluid changes that traditional weight monitoring might miss, helping cardiologists understand patient status earlier and potentially reduce avoidable deterioration and readmissions.
Medical Weight Management
SOZO with BIS technology offers precision in tracking fat mass, lean mass, and fluid status for medical weight management. This allows clinicians to monitor muscle preservation during weight loss, track fat loss, and assess muscle mass in patients on GLP-1 medications, providing a more complete picture than just weight or BMI.
Cancer Survivorship
ImpediMed supports comprehensive cancer survivorship care by integrating fluid and body composition monitoring with lymphedema surveillance. The SOZO platform helps clinicians monitor for lymphedema, track changes in muscle mass and body composition that can occur during treatment, and identify sarcopenia risk, contributing to better long-term patient health and quality of life.
Physician Tip

ImpediMed's SOZO Digital Health Platform utilizes patented Bioimpedance Spectroscopy (BIS) technology, which is a key differentiator. Unlike single or multi-frequency BIA devices, BIS measures impedance at 256 different frequencies (from 3 kHz to 1000 kHz), allowing for direct and accurate measurement of extracellular and intracellular fluid, skeletal muscle mass, and fat mass without relying on population averages. This provides a more precise and individualized assessment, especially for patients with chronic illnesses, obesity, or those undergoing treatments that alter fluid distribution. The SOZO scan is non-invasive, rapid (under 30 seconds), and designed to seamlessly integrate into existing clinical workflows, providing immediate, actionable data at the point of care. The platform offers clear reporting with thresholds, historical data, and longitudinal tracking, enabling clinicians to monitor meaningful changes over time and intervene sooner for improved patient outcomes. Furthermore, SOZO is the only FDA-cleared BIS solution for lymphedema detection and sarcopenia risk assessment, providing a clinically validated and guideline-recommended approach.

The MySOZO cloud-based platform ensures patient data is accessible across care teams, facilitating personalized and coordinated care. Patient data may also be integrated with Electronic Health Records (EHR) for auto-documentation. ImpediMed's technology has also been utilized in clinical trials by pharmaceutical companies like AstraZeneca for monitoring fluid status in heart failure and chronic kidney disease, demonstrating its capability for broader research and clinical applications.

Products by ImpediMed

No products listed for this company yet. Know of one? Suggest it →

Videos

News, demos, and interviews about ImpediMed.

Loading videos...

Videos load interactively. If none appear, search YouTube for ImpediMed →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

ImpediMed offers the SOZO device, which utilizes bioimpedance spectroscopy (BIS) for early lymphedema detection and monitoring. It provides objective, non-invasive measurements to assess fluid changes in limbs, aiding in timely intervention and personalized patient management plans. The data can be integrated into electronic health records for comprehensive patient tracking.
Beyond lymphedema, ImpediMed's BIS technology on the SOZO device can assess whole-body fluid status and body composition, including lean mass and fat mass. This information is valuable for monitoring fluid overload in heart failure patients, assessing sarcopenia risk by tracking lean mass changes, and guiding interventions in medical weight management programs.
The pricing for ImpediMed's devices and services can vary based on the specific product and package. ImpediMed provides comprehensive support including on-site implementation, staff training, and ongoing technical assistance to ensure seamless integration into clinical workflows. They also offer resources for reimbursement guidance.
ImpediMed's BIS technology is supported by numerous peer-reviewed publications demonstrating its accuracy and clinical utility in lymphedema detection, fluid status monitoring, and body composition analysis. The SOZO device is designed for ease of use, which contributes to high patient compliance rates, especially when integrated into routine clinical visits.
ImpediMed collaborates with various healthcare organizations and research institutions to advance the understanding and application of BIS technology. The company has a strong financial foundation and a clear vision for continued innovation in bioimpedance technology, aiming to expand its applications in chronic disease management and preventative health.

Related Companies

TaxMCP is an AI tool designed for tax professionals, including CPAs, enrolled agents, and tax attorneys, to conduct U.S. federal and state tax research. It functions as a research connector that integrates with AI assistants like Claude and ChatGPT, allowing users to access source-linked tax authority directly within their conversational AI environment. Instead of operating […]

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

RTW.ai provides scaled CPA services, offering productized accounting, tax preparation, and quarterly insights specifically for owner-led businesses in healthcare, professional services, and the trades. The company aims to eliminate the common frustrations associated with traditional accounting services, such as slow response times and lack of proactive tax planning. They commit to closing books by the […]

Infinitus is a healthcare AI company that develops voice AI agents and copilots to automate administrative workflows for physicians and healthcare providers. The company aims to reduce the complexity and cost of healthcare by handling time-consuming and repetitive phone-based tasks, such as benefit verifications, prior authorizations, patient outreach, and member engagement. By automating these processes, […]

Trainio is an AI roleplay training platform specifically designed for healthcare teams. It allows medical staff, including front desk personnel, call center agents, caregivers, nurses, and pharmacists, to practice challenging patient and family conversations with realistic AI avatars. These scenarios cover a wide range of situations, such as de-escalation of angry patients, communication with individuals […]

Confido Health is an AI-powered healthcare operations platform designed to alleviate administrative burdens for physicians and healthcare providers. The company develops AI agents that automate routine tasks and workflows across various aspects of healthcare operations, including front, mid, and back office functions. This allows medical staff to dedicate more time to direct patient care, improving […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.